What can you expect from Noldus at SfN 2023?
Whether you are or aren't going to Neuroscience 2023, we would love to give you a sneak preview of our latest innovations!
Zebrafish Research made easy: a dive into the Gerlai Lab
Recently, we published a customer story on the Gerlai Zebrafish Lab in Toronto. In this blog we would like to tell you about the things we learned that could not fit into the video.
Replacing rodents with insects in behavioral testing
In this blog we delve into the use of flies as a new perspective for behavioral testing. How do they compare to rodents? And can conventional rodent tests be adapted to insects?
The value of tracking software: using EthoVision XT to monitor broiler activity
What can EthoVision XT provide over manual observations? We explore that question in the context of a animal welfare study, where fly larvae were provisioned to broilers.
8 reasons why EthoVision XT is the superior video tracking software
Discover the unparalleled efficiency and user-friendliness of EthoVision XT, the superior video tracking platform in behavioral research, offering advanced features and worldwide recognition.
The effect of environmental levels of lead on zebrafish development
Lead exposure has a negative influence on the developing brain and body. Zebrafish research allows us to understand the effects of lead poisoning on the different stages of life.
Diving deeper: Obesity and Anxiety, a scientific perspective
It seems that there is a relationship between poor mental health and obesity. But the exact reasoning is far from clear. Animal experiments can shed light on the situation
Calcium imaging and measuring behavior
What is calcium imaging, and how can you this technique to get a better understanding of complex rodent behavior? Read more about the basic principles and benefits of calcium imaging
6 TED talks to kick off your academic year
Let's get a good warming up for the new academic year. We have compiled six interesting neuroscience TED talks, ranging from optogenetics to AI, to inspire you in the new year.
A 5-HT1A agonist and NMDA antagonist against Parkinson’s disease
Reducing side effects of L-Dopa with 5-HT1A receptor agonists can improve motor activity in a Parkinson’s disease model when combined with NMDA antagonists.